CSO & SVP, Engineering Emami Majid sold $215,105 worth of shares (28,843 units at $7.46), decreasing direct ownership by 6% to 472,983 units (SEC Form 4) to cover taxes
4 - SOUNDHOUND AI, INC. (0001840856) (Issuer)
- Director House Rebecca W gifted 750 shares, decreasing direct ownership by 12% to 5,441 units (SEC Form 4)
4 - Marvell Technology, Inc. (0001835632) (Issuer)
- Large owner Thrivent Financial For Lutherans sold $170,082 worth of shares (35,500 units at $4.79), decreasing direct ownership by 0.75% to 4,719,000 units (SEC Form 4)
4 - Gloo Holdings, Inc. (0002069785) (Issuer)
- Director Hug Joshua sold $503,675 worth of shares (24,533 units at $20.53) as part of a pre-agreed trading plan, decreasing direct ownership by 0.72% to 3,402,257 units (SEC Form 4)
4 - Remitly Global, Inc. (0001782170) (Issuer)
- Chief Operating Officer Horn Margaret A exercised 90,000 shares at a strike of $30.82 and sold $14,972,110 worth of shares (93,575 units at $160.00) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 154,647 units (SEC Form 4) to cover taxes
4 - Revolution Medicines, Inc. (0001628171) (Issuer)
- Chief Technology Officer Rishel Jeremy converted options into 311,862 shares, covered exercise/tax liability with 155,605 shares, sold $1,815,747 worth of shares (102,123 units at $17.78) as part of a pre-agreed trading plan and was granted 1,315 shares, increasing direct ownership by 7% to 895,089 units (SEC Form 4) to cover withholding tax
4 - SoFi Technologies, Inc. (0001818874) (Issuer)
- Director Gebbia Joseph sold $36,704,161 worth of shares (265,000 units at $138.51) as part of a pre-agreed trading plan (SEC Form 4)
4 - Airbnb, Inc. (0001559720) (Issuer)
- Large owner Orbimed Advisors Llc sold $12,668,988 worth of shares (281,408 units at $45.02) (SEC Form 4)
4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)
- Director Boeren Leni was granted 4,160 shares (SEC Form 4)
4 - AEGON LTD. (0000769218) (Issuer)
- SEC Form 4 filed by Director Ho Maykin
4 - KYNTRA BIO, INC. (0000921299) (Issuer)
- SEC Form 4 filed by Director Edwards Jeffrey L
4 - KYNTRA BIO, INC. (0000921299) (Issuer)
- Amendment: SEC Form SCHEDULE 13D/A filed by Enliven Therapeutics Inc.
SCHEDULE 13D/A - Enliven Therapeutics, Inc. (0001672619) (Subject)
- SEC Form 4 filed by Director Kauffman Michael
4 - KYNTRA BIO, INC. (0000921299) (Issuer)
- SEC Form 3 filed by new insider Boeren Leni
3 - AEGON LTD. (0000769218) (Issuer)
- SEC Form 4 filed by Director Schoeneck James A
4 - KYNTRA BIO, INC. (0000921299) (Issuer)